25. 25
Disclaimer
The views and opinions expressed in the following PowerPoint slides are
those of the individual presenter and should not be attributed to Drug
Information Association, Inc. (“DIA”), its directors, officers, employees,
volunteers, members, chapters, councils, Special Interest Area Communities
or affiliates, or any organisation with which the presenter is employed or
affiliated.
These PowerPoint slides are the intellectual property of the individual
presenter and are protected under the copyright laws of the United States of
America and other countries. Used by permission. All rights reserved. Drug
Information Association, DIA and DIA logo are registered trademarks or
trademarks of Drug Information Association Inc. All other trademarks are the
property of their respective owners.
26. 26
Disclosure Statement
Type of Financial Interest within last 12 months Name of Commercial Interest
Grants/Research Funding Synergy-COPD – Modelling and simulation
environment for systems medicine (Chronic
obstructive pulmonary disease -COPD- as a use
case) - FP7-ICT-270086
PROactive project – European project funded by
the Innovative Medicines Initiative (IMI). IMI is a
Joint Initiative (JI) funded by both the EC (via the
FP7 research programme) and EFPIA.
Stock Shareholder Linkcare Health Services, SL
☐ Consulting Fees
Employee Linkcare Health Services, SL
☐ Other (Receipt of Intellectual Property
Rights/Patent Holder, Speaker’s Bureau)